Cisplatin-based chemotherapy for pulmonary metastasized germ cell tumors of the testis - Be aware of acute respiratory distress Syndrome

Onkologie

Volumn 32, Issue 3, 2009, Pages 125-128

  Boeck, Stefan ^a,b   Metzeler, Klaus H ^a   Hausmann, Andreas ^a   Baumann, Anja ^a   Gallmeier, Eike ^a   Parhofer, Klaus G ^a   Stemmler, Hans Joachim ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute respiratory distress syndrome; ARDS; Chemotherapy; Cisplatin; Germ cell tumor

Indexed keywords

ACICLOVIR; CASPOFUNGIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; GERM CELL TUMOR; HUMAN; LUNG METASTASIS; MALE; RISK FACTOR; TESTIS TUMOR;

ANTINEOPLASTIC AGENTS; CISPLATIN; GIANT CELL TUMORS; HUMANS; LUNG NEOPLASMS; MALE; RESPIRATORY DISTRESS SYNDROME, ADULT; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 63849187625     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000197728     Document Type: Article

References (9)

1. Fléchon A, Rivoire M, Droz JP: Management of advanced germ cell tumors of the testis. Nat Clin Pract Urol 2008;5:262-276.
2. Krege S, Beyer J, Souchon R, et al: European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II. Eur Urol 2008;53:497-513.
3. McGowan MP, Pratter MR, Nash G: Primary testicular choriocarcinoma with pulmonary metastasis presenting as ARDS. Chest 1990;97:1258-1259.
4. Moran-Ribon A, Droz JP, Kattan J, Leclercq B, Ghosn M, Couanet D, Ostronoff N, Culine S, Misset B, Escudier B: Super-high-risk germ-cell tumors: a clinical entity. Report of eleven cases. Supp Care Cancer 1994;2:253-258.
5. Kirch C, Blot F, Fizazi K, Raynard B, Theodore C, Nitenberg G: Acute respiratory distress syndrome after chemotherapy for lung metastases from nonseminomatous germ-cell tumors. Supp Care Cancer 2003;11:575-580.
6. Voigt W, Mäher G, Wolf HH, Schmoll HJ: Human chorionic gonadotropin-induced hyperthyroidism in germ cell cancer - a case presentation and review of the literature. Onkologie 2007;30:330-334.
7. Geri A, Lamerz R, Clemm C, Mann K, Hartenstein R, Wilmanns W: Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors? Clin Cancer Res 1996;2:1565-1570.
8. Pfreundschuh M, Trümper L, Kloess M, Schmits R, Feller AC, Rübe C, Rudolph C, Reiser M, Hossfeld DK, Eimermacher H, Hasenclever D, Schmitz N, Loeffler M: Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood 2004;104:634-641.
9. Fizazi K, Massard C, Postel-Vinay S, Escudier B, Culine S, Raynard B, Blot F, Antoun S, Nitenberg G, Plantade A: Chemotherapy for poor prognosis non seminomatous germ cell tumors (NSGCT): Should doses be reduced at first cycle to prevent acute respiratory distress syndrome (ARDS) in patients with multiple lung metastases? J Clin Oncol 2007;25(18S):abstr 5087.